#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



News Efficacy and Safety of Dupilumab in the Treatment of Severe Asthma Insufficiently Controlled by Standard Therapy – Current Clinical Practice Data

If severe bronchial asthma with type 2 inflammation is insufficiently controlled by combined maintenance therapy, dupilumab – a recombinant monoclonal antibody inhibiting the signaling pathway of interleukins 4 and 13 – can be added. What is its efficacy in clinical practice? We summarize findings from 3 recent retrospective studies.
Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation 16. 3. 2023

News EULAR 2023: What Do CRP Levels Reveal About the Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis?

What is the impact of baseline C-reactive protein (CRP) levels on the efficacy and safety of treating ankylosing spondylitis (AS) with the Janus kinase inhibitor (JAKi) tofacitinib? The authors of the cited study below sought to answer this question, with their results presented at this year’s annual EULAR congress, which took place in Milan, Italy, at the traditional turn of May and June.
Source: Arthritis 22. 8. 2023

News Dabigatran as Effective Prevention of VTE Recurrence Also in Patients with Thrombophilia

With increasing positive experience with direct oral anticoagulants, the question arises of how these drugs work in different groups of patients − for example, in those who have a congenital or acquired thrombophilic state.
Source: Anticoagulant Treatment 17. 3. 2020

News Tofacitinib in the Treatment of Ulcerative Colitis in Real-World Practice in the USA

A recently published study summarizes the characteristics of patients newly treated with tofacitinib for ulcerative colitis (UC), the impact of initiating tofacitinib on corticosteroid use, and adherence to this treatment in real-world practice based on a retrospective analysis of data from a large health database in the USA.
Source: Intestinal Inflammations 22. 6. 2023

Journal articles Consultation as the main factor affecting the choice of way of using the combined hormonal contraception: comparison of the CHOICE study results

Author of the article: Tomáš Fait Source: Praktická gynekologie | 2-4/2012 30. 10. 2012

News Subcutaneous zilucoplan – the end of necessary “trips” to the hospital for myasthenia gravis patients?

A study recently published in Lancet Neurology demonstrated the efficacy and safety of the subcutaneously administered complement component C5 inhibitor – zilucoplan – in the treatment of myasthenia gravis (MG). This drug has the potential to alleviate the severity of this disease and improve the quality of life of patients.
Source: Rare Diseases in Neurology 3. 4. 2024

News Will up-titration or combination with bisoprolol help to better control hypertension in amlodipine users?

Will patients with hypertension who do not achieve control of this condition with amlodipine at a dose of 5 mg benefit more from up-titration or combining it with bisoprolol? The answer to this question was sought in a study published this year by German authors.
Source: Cardiovascular Continuum 25. 10. 2022

News New Drug in the Biologic Therapy Arsenal for Plaque Psoriasis

Bimekizumab shows promising effects in clinical studies with psoriasis patients. Let's take a closer look at this recently approved drug in our brief summary.
Source: Psoriasis 25. 4. 2022

News Trifluridine/Tipiracil in the 3rd Line Treatment of mCRC − Case Study

The following case study describes the treatment of a patient with metastatic colorectal cancer (mCRC) and the benefits of trifluridine/tipiracil within the therapeutic algorithm.
Source: Treatment of Gastrointestinal Carcinomas 3. 2. 2021

News Height as an Independent Risk Factor for Varicose Veins

Authors of a study published in the journal Circulation analyzing data from nearly half a million people found another risk factor for the development of varicose veins – a person's height. They further assessed the possible causal role in the development of this pathology.
Source: Venous Insufficiency 1. 3. 2021

News Correct Selection of Appropriate Incontinence Aid is Crucial for Addressing Patient's Difficulties

Urinary incontinence is an uncomfortable issue that can be resolved by choosing the right incontinence aids. Selecting a quality product is most important for the patient − it affects their comfort and mental well-being, but choosing the right aid can also be complicated for doctors. The market offers many products of different brands and qualities, where the absorption capacity is often the main selection criteria. However, other important aspects must also be considered.
Source: Incontinence 12. 5. 2022

News Cell-Based Implant as a Stable System for Biological Therapy Delivery

A team of scientists from Washington University in St. Louis focused on the possibility of delivering biological inhibitors for the treatment of rheumatoid arthritis using modified induced pluripotent stem cells. To verify the effectiveness of the therapy, they used a mouse model of rheumatoid arthritis, and their results represent progress in the development of rheumatoid arthritis treatment.
Source: Arthritis 19. 11. 2021

News Early Detection of Erectile Dysfunction in Men with Type 2 Diabetes

A retrospective study published last year identified predictors of erectile dysfunction in men with type 2 diabetes. The authors recommend screening patients with elevated uric acid levels, diabetes duration ≥ 49 months, and diabetic retinopathy.
Source: Diabetes 18. 7. 2022

Journal articles Implementation and applications of robotic surgery within gynecologic oncology and gynecology; analysis of the first thousand cases

Author of the article: C. Lönnerfors, J. Persson Source: Česká gynekologie | 1/2013 1. 3. 2013

News Administration of Low-Molecular-Weight Heparin After Hemorrhagic Stroke: What Is the Appropriate Timing?

Hemorrhagic stroke (HS) is a condition that raises doubts and concerns about anticoagulation. Is early prevention of thromboembolic complications appropriate?
Source: Thromboprophylaxis 30. 9. 2021

News Meta-analysis of Incidence of Infusion Reactions to Anti-EGFR Antibodies in Patients with mCRC

The application of antibodies against the epidermal growth factor receptor (EGFR), administered in slow infusions mainly as part of the treatment for metastatic colorectal cancer (mCRC), may be accompanied by infusion reactions or hypersensitivity reactions.
Source: Colorectal Cancer 20. 2. 2020

News ESC 2022: Can Modern Treatment of Acute Heart Failure Improve (Re)hospitalization Prevention?

Heart failure (HF) and the possibilities of its therapy were one of the frequently discussed topics at this year's annual congress of the European Society of Cardiology (ESC 2022), which took place at the end of August in Barcelona. The potential of current approaches in reducing the risk of hospitalization or rehospitalization due to HF was also discussed. In summary, we present the insights from a symposium focused directly on this issue.
Source: Chronic Heart Failure and Lipidology 19. 10. 2022

News Chronic Thromboembolic Pulmonary Hypertension – Editorial

Belicová M. Chronic Thromboembolic Pulmonary Hypertension in a Regional Hospital. Vnitř Lék 2011; 57(2): 140–146.
Source: Pulmonary hypertension (CTEPH, PAH) 21. 2. 2020

News Analgesic Effect of Metamizole in Cold-induced Pain

The cold test is used to experimentally induce acute pain – it can thus be used, for example, to test the efficacy of analgesics. The authors of a recently published German study evaluated the analgesic effect and tolerability of metamizole compared to opioid analgesics using this method. They were led by the fact that although the drug has proven clinical efficacy and safety, it has not yet been tested using this procedure, unlike opioids.
Source: Analgesia 5. 10. 2022

News Modern Physical Therapy for Hemophiliacs

Today's physical therapists working with hemophiliacs find themselves in a unique situation - far more effective treatments are available than in past years, leading to a better quality of life. However, it remains necessary to carefully consider what may still have harmful or positive effects on joint health. Dr. Sebastien Lobet from Cliniques universitaires Saint-Luc in Brussels reflected on joint health, sports, and physical therapy in relation to modern treatment for hemophiliacs during the 9th Hemophilia Academy, held online from October 5 to 7.
Source: Hemophilia with Movement 7. 12. 2021

News Effectiveness of Compression Therapy in Patients with Leg Ulcers

Up to 2% of the population suffers from leg ulcers. The standard treatment for ulcers of venous etiology is compression. The following French study, whose results were recently published in the International Journal of Angiology, examined its effectiveness and safety in patients with mixed (arteriovenous) etiology ulcers.
Source: Wound Healing 8. 11. 2022

News Post hoc Analysis of the FRAME Study – Romosozumab in the Treatment of Osteoporosis in the European Population

An interesting finding from the FRAME study, which evaluated the treatment of postmenopausal women with osteoporosis using romosozumab, was the significant differences in fracture incidence among patients from various geographic regions. The following post hoc analysis specifically focused on data from European women.
Source: Osteoporosis – Trends in Sequential Therapy 14. 11. 2023

News Development of Immune Thrombocytopenia as a Result of Past COVID-19 Illness

Immune thrombocytopenia (ITP) developing secondary to COVID-19 is a completely new experience in clinical practice. A brief summary on this topic, describing incidence and response to treatment, was published last year by authors from Cleveland.
Source: Immune Thrombocytopenia 5. 10. 2022

News Efficacy and Safety of Etanercept in the Therapy of Arthritis

A review by experts from Genoa, Italy, focused on the available knowledge regarding the efficacy and safety of etanercept in the treatment of inflammatory rheumatic diseases.
Source: Arthritis 7. 6. 2022

News Familial Hypercholesterolemia and COVID-19: Connections and Risks

Patients with familial hypercholesterolemia (FH) likely have a higher risk of COVID-19 complications both in the acute phase of the infection and for a relatively long period after its occurrence.
Source: Hypercholesterolemia 18. 3. 2021

1 14 15 16 17 18 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#